WO2006092732A3 - Stable solid dosage form of antihypertensive agent - Google Patents
Stable solid dosage form of antihypertensive agent Download PDFInfo
- Publication number
- WO2006092732A3 WO2006092732A3 PCT/IB2006/000535 IB2006000535W WO2006092732A3 WO 2006092732 A3 WO2006092732 A3 WO 2006092732A3 IB 2006000535 W IB2006000535 W IB 2006000535W WO 2006092732 A3 WO2006092732 A3 WO 2006092732A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solid dosage
- stable solid
- antihypertensive agent
- dosage form
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to stable pharmaceutical compositions of antihypertensive agent. More particularly, the present invention relates to stable solid dosage forms of benazepril hydrochloride. The invention also relates to a process for the preparation of stable solid dosage forms of benazepril hydrochloride.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN208/CHE/2005 | 2005-03-04 | ||
IN208CH2005 | 2005-03-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006092732A2 WO2006092732A2 (en) | 2006-09-08 |
WO2006092732A3 true WO2006092732A3 (en) | 2007-03-29 |
Family
ID=36941544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/000535 WO2006092732A2 (en) | 2005-03-04 | 2006-02-28 | Stable solid dosage form of antihypertensive agent |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006092732A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008147601A1 (en) * | 2007-04-17 | 2008-12-04 | University Of Florida Research Foundation, Inc. | Methods and compositions for ameliorating thiazide induced hyperlipidemia |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002049646A1 (en) * | 2000-12-18 | 2002-06-27 | Novartis Ag | Therapeutic combination of amlodipine and benazepril/benazeprilat |
US20020183308A1 (en) * | 2001-04-12 | 2002-12-05 | Sherman Bernard Charles | Benazepril Hydrochloride tablet formulations |
-
2006
- 2006-02-28 WO PCT/IB2006/000535 patent/WO2006092732A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002049646A1 (en) * | 2000-12-18 | 2002-06-27 | Novartis Ag | Therapeutic combination of amlodipine and benazepril/benazeprilat |
US20020183308A1 (en) * | 2001-04-12 | 2002-12-05 | Sherman Bernard Charles | Benazepril Hydrochloride tablet formulations |
Non-Patent Citations (3)
Title |
---|
"Rote Liste 1996", 1996, ECV EDITIO CANTOR, FRANKFURT/MAIN, XP002411573 * |
"Rote Liste 1996", 1996, ECV EDITIO CANTOR, FRANKFURT/MAIN, XP002411574 * |
LI SHOUFENG ET AL: "Correlation and prediction of moisture-mediated dissolution stability for benazepril hydrochloride tablets", PHARMACEUTICAL RESEARCH (DORDRECHT), vol. 21, no. 4, April 2004 (2004-04-01), pages 617 - 624, XP002411560, ISSN: 0724-8741 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006092732A2 (en) | 2006-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006074951A3 (en) | Orally disintegrating composition of olanzapine or donepezil | |
WO2007052289A3 (en) | Novel dispersible tablet composition | |
AP2006003522A0 (en) | Yd-crystalline form of ivabradine hydrochloride, a process for its preparation adn pharmaceutical compositions containing it. | |
AP2303A (en) | d-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. | |
WO2005067893A3 (en) | Pharmaceutical compositions comprising midazolam in a high concentration | |
AP2006003521A0 (en) | Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. | |
WO2008027542A3 (en) | 5-substituted isoindoline compounds | |
WO2008013838A3 (en) | Pyridizinone derivatives | |
WO2006082523A3 (en) | Pharmaceutical sustained release composition of metformin | |
WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
MX2009004746A (en) | 1,2,4-triazole derivatives as sigma receptor inhibitors. | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2006123243A3 (en) | Pharmaceutical dosage forms comprising escitalopram in form of granules | |
WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
WO2008065485A3 (en) | Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor | |
WO2007000655A3 (en) | Novel pyrazolopyrimidinone derivatives | |
WO2009013594A3 (en) | Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process | |
WO2008059298A3 (en) | Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form | |
WO2006092732A3 (en) | Stable solid dosage form of antihypertensive agent | |
WO2008068569A3 (en) | Processes for the preparation of clopidogrel hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06710534 Country of ref document: EP Kind code of ref document: A2 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 6710534 Country of ref document: EP |